Christopher H. Lieu

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

Ben Tran, Scott Kopetz, Jeanne Tie et al. · Cancer · 2011 · 801 citations · Full text

Medicine, Oncology, Pathology +17

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Manisha H. Shah, Whitney Goldner, Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2021 · 602 citations

Medicine, Nuclear Medicine, Oncology +17

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris et al. · Journal of Clinical Oncology · 2009 · 487 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

Scott Kopetz, Katherine A. Guthrie, Van K. Morris et al. · Journal of Clinical Oncology · 2020 · 391 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

Manisha H. Shah, Whitney Goldner, Þorvarður R. Hálfdánarson et al. · Journal of the National Comprehensive Cancer Network · 2018 · 391 citations · Full text

Medicine, Oncology, Surgery +17